🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/12/2001 | 62,77 | 64,98 | 62,32 | 64,15 | +1,72% | 4,23% | 119.263 |
| 04/12/2001 | 63,26 | 63,82 | 60,75 | 63,07 | +0,00% | 4,85% | 103.741 |
| 03/12/2001 | 62,55 | 64,01 | 61,80 | 63,07 | +2,00% | 3,53% | 104.489 |
| 30/11/2001 | 60,00 | 62,66 | 58,95 | 61,83 | +2,48% | 6,18% | 425.089 |
| 29/11/2001 | 56,97 | 60,45 | 56,71 | 60,34 | +5,98% | 6,57% | 131.820 |
| 28/11/2001 | 61,16 | 61,20 | 56,74 | 56,93 | -6,40% | 7,28% | 213.974 |
| 27/11/2001 | 59,48 | 62,69 | 59,10 | 60,82 | +1,56% | 6,04% | 166.445 |
| 26/11/2001 | 55,77 | 62,13 | 55,21 | 59,89 | +8,47% | 12,42% | 223.191 |
| 23/11/2001 | 54,57 | 55,25 | 53,71 | 55,21 | +0,00% | 2,81% | 35.693 |
| 21/11/2001 | 50,23 | 55,21 | 50,19 | 55,21 | +9,99% | 9,99% | 65.242 |
| 20/11/2001 | 51,95 | 52,36 | 50,19 | 50,19 | -4,21% | 4,18% | 30.430 |
| 19/11/2001 | 51,09 | 52,40 | 49,67 | 52,40 | +3,63% | 5,35% | 41.705 |
| 16/11/2001 | 49,41 | 50,90 | 49,41 | 50,57 | +2,35% | 3,03% | 53.193 |
| 15/11/2001 | 49,97 | 50,68 | 49,18 | 49,41 | -1,49% | 3,00% | 41.571 |
| 14/11/2001 | 49,59 | 51,09 | 49,22 | 50,16 | +1,36% | 3,77% | 78.734 |
| 13/11/2001 | 47,72 | 49,52 | 46,79 | 49,48 | +4,34% | 5,73% | 70.265 |
| 12/11/2001 | 46,11 | 47,54 | 44,92 | 47,42 | +1,69% | 5,68% | 27.011 |
| 09/11/2001 | 48,47 | 48,58 | 45,48 | 46,64 | -3,86% | 6,41% | 55.116 |
| 08/11/2001 | 49,37 | 49,59 | 48,47 | 48,51 | -1,07% | 2,27% | 74.192 |
| 07/11/2001 | 48,81 | 49,67 | 48,21 | 49,03 | +0,46% | 2,99% | 41.678 |
| 06/11/2001 | 48,66 | 48,92 | 47,31 | 48,81 | +2,11% | 3,31% | 47.743 |
| 05/11/2001 | 47,16 | 48,92 | 47,16 | 47,80 | +1,75% | 3,73% | 38.606 |
| 02/11/2001 | 49,03 | 49,22 | 46,94 | 46,97 | -4,92% | 4,66% | 59.979 |
| 01/11/2001 | 49,59 | 50,53 | 48,06 | 49,41 | -2,00% | 4,98% | 48.170 |
| 31/10/2001 | 47,05 | 50,49 | 46,60 | 50,42 | +6,90% | 8,27% | 91.157 |
| 30/10/2001 | 44,95 | 48,51 | 44,77 | 47,16 | -3,45% | 8,33% | 94.363 |
| 29/10/2001 | 51,13 | 51,88 | 47,54 | 48,85 | -4,04% | 8,49% | 114.053 |
| 26/10/2001 | 48,66 | 51,28 | 48,66 | 50,90 | +1,64% | 5,38% | 67.299 |
| 25/10/2001 | 47,39 | 50,08 | 47,35 | 50,08 | +2,69% | 5,77% | 78.066 |
| 24/10/2001 | 47,39 | 49,15 | 46,60 | 48,77 | +1,80% | 5,37% | 103.981 |